SAB Biotherapeutics, Inc. (SABS) News & Overview - Discounting Cash Flows
SABS
SAB Biotherapeutics, Inc.
SABS (NASDAQ)

SABS's Business Model

SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies based on human antibodies. It has applied advanced genetic engineering and antibody science to develop transchromosomic bovine herds that produce fully human antibodies targeted at specific diseases, including infectious diseases comprising COVID-19 and influenza, immune and autoimmune disorders, such as type 1 diabetes, organ transplantation, and cancer. The company uses its DiversitAb immunotherapy platform to produce fully-human polyclonal antibodies without the need for human donors. Its lead product candidates include SAB-185, a fully-human polyclonal antibody therapeutic candidate that is in Phase III clinical trial for the treatment of COVID-19; and SAB-176, a fully-human polyclonal antibody therapeutic candidate that is in development to treat or prevent severe influenza. The company's pre-clinical product candidates in development for autoimmune diseases include SAB-142 for type 1 diabetes and organ transplant induction/rejection. The company was founded in 2014 and is based in Sioux Falls, South Dakota.
Sector & Industry Healthcare / Biotechnology
Website https://www.sabbiotherapeutics.com
CEO (Chief Executive Officer) Samuel J. Reich
Number of Employees
IPO date February 9, 2021

SABS Latest News

Contact
CountryUS
Address2100 East 54th Street North
CitySioux Falls
StateSD
Phone605 679 6980
Zip Code57104
Other Identifiers
CIK0001833214
ISINUS78397T2024
CUSIP78397T103
Open1.75
Previous Close1.75
Volume14.06 Thou.
Average Volume40.89 Thou.
Day’s Range1.715 – 1.819
52 Week Range1-5.01
MA (50)1.77528
MA (200)2.43147
Market Cap15.98 Mil.
Shares Out.9.29 Mil.
Earnings DateAug 06, 2025
Beta
Last Dividend
EPS
PE

Industry Competitors for SABS

discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us